CA2129676A1 - Compositions antitussive de dextromethorphane - Google Patents
Compositions antitussive de dextromethorphaneInfo
- Publication number
- CA2129676A1 CA2129676A1 CA 2129676 CA2129676A CA2129676A1 CA 2129676 A1 CA2129676 A1 CA 2129676A1 CA 2129676 CA2129676 CA 2129676 CA 2129676 A CA2129676 A CA 2129676A CA 2129676 A1 CA2129676 A1 CA 2129676A1
- Authority
- CA
- Canada
- Prior art keywords
- dextromethorphan
- antitussive compositions
- compositions
- dextromethorphan antitussive
- composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US60629490A | 1990-10-31 | 1990-10-31 | |
| US606,294 | 1990-10-31 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2129676A1 true CA2129676A1 (fr) | 1992-05-14 |
| CA2129676C CA2129676C (fr) | 1997-09-30 |
Family
ID=24427392
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002129676A Expired - Fee Related CA2129676C (fr) | 1990-10-31 | 1991-10-21 | Compositions antitussive de dextromethorphane |
Country Status (13)
| Country | Link |
|---|---|
| EP (1) | EP0555411A1 (fr) |
| JP (1) | JPH06502428A (fr) |
| AU (1) | AU663857B2 (fr) |
| CA (1) | CA2129676C (fr) |
| CZ (1) | CZ79593A3 (fr) |
| FI (1) | FI931934A7 (fr) |
| HU (1) | HUT64216A (fr) |
| IE (1) | IE913792A1 (fr) |
| MX (1) | MX9101831A (fr) |
| PL (1) | PL168968B1 (fr) |
| PT (1) | PT99380B (fr) |
| SK (1) | SK42593A3 (fr) |
| WO (1) | WO1992007559A1 (fr) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1274026B (it) * | 1994-03-01 | 1997-07-14 | Acraf | Composizione antitosse |
| SE9601528D0 (sv) * | 1996-04-23 | 1996-04-23 | Pharmacia Ab | Transdermally administered dextromethorphan as antitissue agent |
| WO1999003474A1 (fr) * | 1997-07-15 | 1999-01-28 | Walter Burghart | Procede pour preparer des solutions stables d'acide acetylsalicylique |
| US6245785B1 (en) | 1998-11-30 | 2001-06-12 | Warner Lambert Company | Dissolution of triprolidine hydrochloride |
| US6846495B2 (en) * | 1999-01-11 | 2005-01-25 | The Procter & Gamble Company | Compositions having improved delivery of actives |
| DE102007000521A1 (de) | 2007-10-18 | 2009-04-23 | Renate Conrad | Hustenpräparat |
| EP3544631A1 (fr) | 2016-11-28 | 2019-10-02 | Johnson & Johnson Consumer Inc. | Compositions liquides comprenant un agent mucoadhésif |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4294819A (en) * | 1980-08-18 | 1981-10-13 | Bristol-Myers Company | Alkaline analgesic capsule |
| US4454140A (en) * | 1982-09-07 | 1984-06-12 | Hoffmann-La Roche Inc. | Nasal administration of dextromethorphan |
| US4427681A (en) * | 1982-09-16 | 1984-01-24 | Richardson-Vicks, Inc. | Thixotropic compositions easily convertible to pourable liquids |
| US4892877A (en) * | 1987-10-27 | 1990-01-09 | Richardson-Vicks Inc. | Antitussive liquid compositions containing phenol |
-
1991
- 1991-10-21 CA CA002129676A patent/CA2129676C/fr not_active Expired - Fee Related
- 1991-10-21 HU HU9301254A patent/HUT64216A/hu unknown
- 1991-10-21 CZ CS93795A patent/CZ79593A3/cs unknown
- 1991-10-21 FI FI931934A patent/FI931934A7/fi unknown
- 1991-10-21 WO PCT/US1991/007773 patent/WO1992007559A1/fr not_active Ceased
- 1991-10-21 SK SK42593A patent/SK42593A3/sk unknown
- 1991-10-21 PL PL91298950A patent/PL168968B1/pl unknown
- 1991-10-21 JP JP4500771A patent/JPH06502428A/ja active Pending
- 1991-10-21 AU AU89158/91A patent/AU663857B2/en not_active Ceased
- 1991-10-21 EP EP92902567A patent/EP0555411A1/fr not_active Ceased
- 1991-10-29 MX MX9101831A patent/MX9101831A/es not_active IP Right Cessation
- 1991-10-30 IE IE379291A patent/IE913792A1/en not_active Application Discontinuation
- 1991-10-30 PT PT99380A patent/PT99380B/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| FI931934A0 (fi) | 1993-04-29 |
| MX9101831A (es) | 1992-06-05 |
| JPH06502428A (ja) | 1994-03-17 |
| EP0555411A1 (fr) | 1993-08-18 |
| AU8915891A (en) | 1992-05-26 |
| CA2129676C (fr) | 1997-09-30 |
| HUT64216A (en) | 1993-12-28 |
| AU663857B2 (en) | 1995-10-26 |
| PL168968B1 (en) | 1996-05-31 |
| FI931934L (fi) | 1993-05-31 |
| HU9301254D0 (en) | 1993-07-28 |
| PT99380B (pt) | 1999-04-30 |
| PT99380A (pt) | 1992-09-30 |
| WO1992007559A1 (fr) | 1992-05-14 |
| IE913792A1 (en) | 1992-05-22 |
| SK42593A3 (en) | 1993-09-08 |
| FI931934A7 (fi) | 1993-05-31 |
| CZ79593A3 (en) | 1994-01-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ITRM910696A0 (it) | Composizioni farmaceutiche per l'applicazione per via nasale. | |
| OA09772A (en) | "mometasone furoate monohydrate, process for making same and pharmaceutical compositions". | |
| PH31059A (en) | Pharmaceutical compositions comprising cyclosporins. | |
| NZ236581A (en) | 3-amino piperidine derivatives, analogues and pharmaceutical compositions | |
| FR2677984B1 (fr) | Derives d'imidazoline n-substitues, leur preparation, les compositions pharmaceutiques en contenant. | |
| NZ240378A (en) | Substituted thiazolidinedione derivatives; pharmaceutical compositions, | |
| AU5157590A (en) | Pharmaceutical compositions for oral administration | |
| IL99030A0 (en) | 1,4-dihydropyridine derivatives,processes for the preparation thereof and pharmaceutical compositions containing the same | |
| CA2101648A1 (fr) | Conjugues polysaccharide-proteine | |
| AU3019292A (en) | Pharmaceutical compositions for peroral administration | |
| AU1252592A (en) | Swallowable pharmaceutical compositions | |
| AU1227292A (en) | Pharmaceutical antitussive compositions | |
| CA2129676A1 (fr) | Compositions antitussive de dextromethorphane | |
| CA2220019A1 (fr) | Composition pharmaceutique contenant de l'hydrochlorure de tiagabine et procede de preparation | |
| CA2218643A1 (fr) | Composition pharmaceutique orale de composes de piperidinoalcanol sous forme de solutions | |
| IL100955A (en) | Amino-polyhydroxy- cyclopentane derivatives, processes for the preparation thereof, and pharmaceutical compositions containing the same | |
| AU8522491A (en) | Substituted imidazoles, their preparation and pharmaceutical compositions | |
| GB9111314D0 (en) | Pharmaceutical compositions | |
| ZA918381B (en) | Pharmaceutical compositions. | |
| NZ237442A (en) | 1,6,7,9-tetrahydroxy-11-oxolabdane derivatives; their preparation and pharmaceutical compositions | |
| FR2685204B1 (fr) | Compositions pharmaceutiques pour l'administration transcutanee de la fenfluramine. | |
| HK27096A (en) | Benzofuranylimidazole derivatives | |
| AU8490991A (en) | Substituted 2 imidazolone derivatives, their preparation and pharmaceutical compositions | |
| ES8801267A1 (es) | Procedimiento para preparar derivados de isoquinolinona | |
| FR2659967B1 (fr) | Derives d'imidazolinone n-substitues, leur preparation, les compositions pharmaceutiques en contenant. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKLA | Lapsed |